Fish oil is oil derived from the tissues of oily fish. Fish oils contain the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), precursors of certain eicosanoids that are known to reduce inflammation in the body, and have other health benefits.
Fish do not actually produce omega-3 fatty acids, but instead accumulate them by consuming either microalgae or prey fish that have accumulated omega-3 fatty acids, together with a high quantity of antioxidants such as iodide and selenium, from microalgae, where these antioxidants are able to protect the fragile polyunsaturated lipids from peroxidation.
Fatty predatory fish like sharks, swordfish, tilefish, and albacore tuna may be high in omega-3 fatty acids, but due to their position at the top of the food chain, these species may also accumulate toxic substances through biomagnification. For this reason, the U.S. Food and Drug Administration recommends limiting consumption of certain (predatory) fish species (e.g. albacore tuna, shark, king mackerel, tilefish and swordfish) due to high levels of toxic contaminants such as mercury, dioxin, PCBs and chlordane. Fish oil is used as a component in aquaculture feed. More than 50 percent of the world's fish oil used in aquaculture feed is fed to farmed salmon.
Marine and freshwater fish oil vary in contents of arachidonic acid, EPA and DHA. The various species range from lean to fatty and their oil content in the tissues has been shown to vary from 0.7–15.5%. They also differ in their effects on organ lipids. Studies have revealed that there is no relation between total fish intake or estimated omega−3 fatty acid intake from all fish, and serum omega−3 fatty acid concentrations. Only fatty fish intake, particularly salmonid, and estimated EPA + DHA intake from fatty fish has been observed to be significantly associated with increase in serum EPA + DHA.
The omega-3 fatty acids in fish oil are thought to be beneficial in treating hypertriglyceridemia, and possibly beneficial in preventing heart disease. Fish oil and omega-3 fatty acids have been studied in a wide variety of other conditions, such as clinical depression, anxiety, cancer, and macular degeneration, although benefit in these conditions remains to be proven.
- 1 Background
- 2 Production
- 3 Health benefits
- 4 Supplement quality and concerns
- 5 Dangers
- 6 See also
- 7 Notes
- 8 References
- 9 External links
The most widely available dietary source of EPA and DHA is cold water oily fish, such as salmon, herring, mackerel, anchovies, and sardines. Oils from these fish have a profile of around seven times as much omega-3 oils as omega-6 oils. Other oily fish, such as tuna, also contain omega-3 in somewhat lesser amounts. Although fish is a dietary source of omega-3, fish do not synthesize them; they obtain them from the algae (microalgae in particular) or plankton in their diets.
|Spanish mackerel, Atlantic, Pacific||1.1–1.7|
|Tuna (canned, light)||0.17–0.24|
|Hoki (blue grenadier)||0.41|
|Blue eye cod||0.31|
|Sydney rock oysters||0.30|
|Giant tiger prawn||0.100|
For comparison, here are the omega-3 levels in some common non-fish foods.
|Eggs, large regular||0.109|
|Lean red meat||0.031|
|Cereals, rice, pasta, etc.||0.00|
In 2005, fish oil production declined in all main producing countries with the exception of Iceland. The 2005 production estimate is about 570,000 tonnes in the five main exporting countries (Peru, Denmark, Chile, Iceland and Norway), a 12% decline from the 650,000 tonnes produced in 2004. Peru continues to be the main fish oil producer worldwide, with about one fourth of total fish oil production.
Several studies report possible anti-cancer effects of n−3 fatty acids found in fish oil (particularly breast, colon and prostate cancer). Among n-3 fatty acids (omega-3), neither long-chain nor short-chain forms were consistently associated with reduced breast cancer risk. High levels of docosahexaenoic acid, however, the most abundant n-3 polyunsaturated fatty acid (omega-3) in erythrocyte membranes, were associated with a reduced risk of breast cancer. A recent study of 35,000 middle-aged women found that the women who took fish oil supplements had a 32% lower risk of breast cancer, although the authors stress the result is preliminary and falls short of establishing a causal relationship. Omega-3 fatty acids reduced prostate cancer growth, slowed histopathological progression, and increased survival in genetically engineered mice. However the effects of fish oil consumption by humans on prostate cancer is not conclusive. There is a decreased risk with higher blood levels of DPA, but an increased risk of more aggressive prostate cancer with higher blood levels of combined EPA and DHA.
The American Heart Association recommends the consumption of 1 gram of fish oil daily, preferably by eating fish, for patients with coronary artery disease, but cautions pregnant and nursing women to avoid eating fish with high potential for mercury contaminants including mackerel, shark, and swordfish. Optimal dosage relates to body weight.
The US National Institutes of Health lists three conditions for which fish oil and other omega-3 sources are most highly recommended: hypertriglyceridemia (high triglyceride level), preventing secondary cardiovascular disease, and hypertension (high blood pressure). It then lists 27 other conditions for which there is less evidence. It also lists possible safety concerns: "Intake of 3 grams per day or greater of omega-3 fatty acids may increase the risk of bleeding, although there is little evidence of significant bleeding risk at lower doses. Very large intakes of fish oil/omega-3 fatty acids may increase the risk of hemorrhagic (bleeding) stroke."
A 2008 meta-study by the Canadian Medical Association Journal found fish oil supplementation did not demonstrate any preventative benefit to cardiac patients with ventricular arrhythmias. A 2012 meta-analysis published in the Journal of the American Medical Association, covering 20 studies and 68,680 patients, found that Omega-3 Fatty Acid supplementation did not reduce the chance of death, cardiac death, heart attack or stroke.
There have been some human trials that have concluded that consuming omega-3 fatty acids slightly reduces blood pressure (DHA could be more effective than EPA). It is important to note that because omega-3 fatty acids can increase the risk of bleeding, a qualified healthcare provider should be consulted before supplementing with fish oil.
Studies published in 2004 and 2009 have suggested that the n-3 EPA may reduce the risk of depression and suicide. One study compared blood samples of 100 suicide-attempt patients to those of controls and found that levels of Eicosapentaenoic acid were significantly lower in the washed red blood cells of the suicide-attempt patients. A small American trial in 2009 suggested that E-EPA, as monotherapy, might treat major depressive disorder but failed to achieve statistical significance.
Studies were conducted on prisoners in England where the inmates were fed seafood which contains omega-3 fatty acids. The higher consumption of these fatty acids corresponded with a drop in the assault rates. Reduced levels of aggression have also been found in schoolchildren and young adults when their diets were supplemented with fish oil.
A study from the Orygen Research Centre in Melbourne suggests that omega-3 fatty acids could also help delay or prevent the onset of schizophrenia. The researchers enlisted 81 'high risk' young people aged 13 to 24 who had previously suffered brief hallucinations or delusions and gave half of them capsules of fish oil while the other half received placebo. One year on, only three percent of those on fish oil had developed schizophrenia compared to 28 percent from those on placebo. A study conducted at Sheffield University in England reported positive results with fish oil on patients suffering from schizophrenia. Participants of the study had previously taken anti-psychotic prescription drugs that were no longer effective. After taking fish oil supplements, participants in the study experienced progress compared to others who were given a placebo.
Evidence regarding the efficacy of fish oil supplements as a treatment for depression is inconclusive. Whereas several methodologically rigorous studies have reported statistically significant positive effects in the treatment of depressed patients, other studies have found effects to be insignificant.
In 1999 a team of researchers lead by the Harvard psychiatrist Andrew Stoll published a preliminary placebo-controlled double blind trial which found Omega 3 fatty acids "improved the short-term course of illness" of bipolar disorder. He credits Donald O. Rudin for pioneering this view in 1981.
A 2003 double-blind placebo-controlled study published in the journal European Neuropsychopharmacology found that among 28 patients with major depressive disorder, "patients in the omega-3 PUFA group had a significantly decreased score on the 21-item Hamilton Rating Scale for Depression than those in the placebo group." Another study in the American Journal of Psychiatry reported that the addition of fish oil supplements to regular maintenance anti-depression therapy conferred "highly significant" benefits by the third week of the trial.
A 2005 randomized double-blind placebo-controlled study conducted under the auspices of the New Zealand Institute for Crop and Food Research found "no evidence that fish oil improved mood when compared to placebo, despite an increase in circulating ω-3 polyunsaturated fatty acids." Another study published in October 2007 found that fish oil supplements conferred no additional benefits beyond those conferred by standard treatment. However, both of these studies used omega-3 primary consisting of DHA, not EPA.
A 2008 Cochrane systematic review found that limited data is available. In the one eligible study, omega-3s were an effective adjunctive therapy for depressed but not manic symptoms in bipolar disorder. The authors found an "acute need" for more randomised controlled trials.
A 2009 metastudy found that patients taking omega-3 supplements with a higher EPA:DHA ratio experienced less depressive symptoms. The studies provided evidence that EPA may be more efficacious than DHA in treating depression. However, this metastudy concluded that due to the identified limitations of the included studies, larger, randomized trials are needed to confirm these findings.
In a 2011 meta-analysis of PubMed articles about fish oil and depression from 1965–2010, researchers found that "nearly all of the treatment efficacy observed in the published literature may be attributable to publication bias."
A Cochrane meta-analysis published in June 2012 found no significant protective effect for cognitive decline for those aged 60 and over and who started taking fatty acids after this age. A co-author of the study said to Time, "Our analysis suggests that there is currently no evidence that omega-3 fatty acid supplements provide a benefit for memory or concentration in later life".
In a study conducted in Northern Ireland, lupus disease activity, especially in the skin and joints, was significantly reduced in patients who received fish oil supplements at both 12-week and 24-week follow-up periods versus patients who received placebo. There were also changes in the blood platelets of the patients who took the fish oil supplements, with an increase in proteins that are considered anti-inflammatory and a decrease in proteins that promote inflammation; these changes were not evident in the group that took placebo. The fish oil group showed an increase in flow-mediated dilation, which the researchers took as a sign that the omega-3 oils were helping the cells in the blood vessel walls to remain healthy.
Some studies reported better psycho motor development at 30 months of age in infants whose mothers received fish oil supplements for the first four months of lactation. In addition, five-year-old children whose mothers received modest algae based docosahexaenoic acid supplementation for the first 4 months of breastfeeding performed better on a test of sustained attention. This suggests that docosahexaenoic acid intake during early infancy confers long-term benefits on specific aspects of neurodevelopment.
In addition, provision of fish oil during pregnancy may reduce an infant’s sensitization to common food allergens and reduce the prevalence and severity of certain skin diseases in the first year of life. This effect may persist until adolescence with a reduction in prevalence and/or severity of eczema, hay fever and asthma.
Supplement quality and concerns
Fish oil is now one of the most popular dietary supplements on the market, with sales reaching $976 million in 2009. However, neither the FDA nor any other federal or state agency routinely tests fish or marine oil supplements for quality prior to sale. Problems of quality have been identified in periodic tests by independent researchers of marketed supplements containing fish oil and other marine oils. These problems include contamination, inaccurate listing of EPA and DHA levels, spoilage and formulation issues.
Fish can accumulate toxins such as mercury, dioxins, and polychlorinated biphenyls (PCBs), and spoiled fish oil may produce peroxides. There appears to be little risk of contamination by microorganisms, proteins, lysophospholipids, cholesterol, and trans-fats.
While a serving of fish may contain anywhere from 10 to 1,000 ppb of mercury, fish oil supplements have not been found to contain similar mercury levels. Reasons for this are 1) smaller fish are typically used in making fish oil supplements and they tend to be lower on the food chain and contain less mercury; 2) mercury binds to protein (such as in fish meat) and not to oil; and 3) mercury may be reduced or removed during the processing of fish oil. (most fish oils are distilled)
Dioxins and PCBs
Dioxins and PCBs may be carcinogenic at low levels of exposure over time. These substances are identified and measured in one of two categories, dioxin-like PCBs and total PCBs. While the U.S. FDA has not set a limit for PCBs in supplements, the Global Organization for EPA and DHA (GOED) has established a guideline allowing for no more than 3 picograms of dioxin-like PCBs per gram of fish oil. In 2012, samples from 35 fish oil supplements were tested for PCBs. Trace amounts of PCBs were found in all samples, and two samples exceeded the GOED‘s limit. Although trace amounts of PCBs contribute to overall PCB exposure, Consumerlab.com claims the amounts reported by tests it ordered on fish oil supplements are far below those found in a single typical serving of fish.
Peroxides can be produced when fish oil spoils. A study commissioned by the government of Norway concluded there would be some health concern related to the regular consumption of oxidized (rancid) fish/marine oils, particularly in regards to the gastrointestinal tract, but there is not enough data to determine the risk. The amount of spoilage and contamination in a supplement depends on the raw materials and processes of extraction, refining, concentration, encapsulation, storage and transportation. ConsumerLab.com reports in its review that it found spoilage in test reports it ordered on some fish oil supplement products.
EPA and DHA content
Some countries[which?] recommend a combined daily intake of 300 – 500 mg while some countries like the US do not have a recommendation for EPA and DHA. The American Heart Association recommends 250–500 mg/day of EPA and DHA. In the United States the FDA recommends not exceeding 3 grams per day of EPA and DHA omega-3 fatty acids, with no more than 2 grams per day from a dietary supplement.
According to independent laboratory[which?] tests, the concentrations of EPA and DHA in supplements can vary from between 8 to 80% fish oil content. The concentration depends on the source of the omega-3s, how the oil is processed, and the amounts of other ingredients included in the supplement. A 2012 report claims 4 of 35 fish oil supplements it covered contained less[quantify] EPA or DHA than was claimed on the label, and 3 of 35 contained more[quantify] A ConsumberLab.com publication in 2010 claims 3 of 24 fish oil supplements it covered contained less[quantify] EPA and/or DHA than was claimed on the label.
Fish oil supplements are available as liquids, capsules, and tablets. Some pills are enteric-coated to help prevent indigestion or "fish burps", however; enteric-coated products have the potential to release ingredients too early or late in the digestive process. In 2010 ConsumerLab.com reports that one of 24 fish oil supplements[which?] with enteric-coated pill released ingredients prematurely[clarification needed] ; Consumerlab.com claims in its publication that there were problems in results of tests it ordered in 2012. Fish oils are best tolerated when taken with meals, and, if possible, should be taken in equally divided doses throughout the day.
A 2013 review concluded that that the potential for adverse events amongst older adults taking fish oil "appear mild–moderate at worst and are unlikely to be of clinical significance".
The FDA says it is safe to take up to 3000 mg of omega-3 per day. (This is not the same as 3000 mg of fish oil. A 1000 mg pill typically has only 300 mg of omega-3; 10 such pills would equal 3000 mg of omega-3.) Dyerberg studied healthy Greenland Eskimos and found an average intake of 5700 mg of omega-3 EPA per day.
The liver and liver products (such as cod liver oil) of fish and many animals (such as seals and whales) contain omega-3, but also the active form of vitamin A. At high levels, this form of the vitamin can be dangerous (Hypervitaminosis A).
Consumers of oily fish should be aware of the potential presence of heavy metals and fat-soluble pollutants like PCBs and dioxins, which are known to accumulate up the food chain. After extensive review, researchers from Harvard's School of Public Health in the Journal of the American Medical Association (2006) reported that the benefits of fish intake generally far outweigh the potential risks.
Fish oil supplements came under scrutiny in 2006, when the Food Standards Agency in the UK and the Food Safety Authority of Ireland reported PCB levels that exceeded the European maximum limits in several fish oil brands, which required temporary withdrawal of these brands. To address the concern over contaminated fish oil supplements, the International Fish Oil Standards (IFOS) Program, a third-party testing and accreditation program for fish oil products, was created by Nutrasource Diagnostics Inc. in Guelph, Ontario, Canada.
A March 2010 lawsuit filed by a California environmental group claimed that eight brands of fish oil supplements contained excessive levels of PCB's, including CVS/pharmacy, Nature Made, Rite Aid, GNC, Solgar, Twinlab, Now Health, Omega Protein and Pharmavite. The majority of these products were either cod liver or shark liver oils. Those participating in the lawsuit claim that because the liver is the major filtering and detoxifying organ, PCB content may be higher in liver-based oils than in fish oil produced from the processing of whole fish.
An analysis based on data from the Norwegian Women and Cancer Study (NOWAC) with regards to the dangers of persistent organic pollutants (POPs) in cod liver came to the conclusion that "in Norwegian women, fish liver consumption was not associated with an increased cancer risk in breast, uterus, or colon. In contrast, a decreased risk for total cancer was found."
However, a report by the Harvard Medical School studied five popular brands of fish oil, including Nordic Ultimate, Kirkland and CVS. They found that the brands had "negligible amounts of mercury, suggesting either that mercury is removed during the manufacturing of purified fish oil or that the fish sources used in these commercial preparations are relatively mercury-free." Microalgae oil is a vegetarian alternative to fish oil. Supplements produced from microalgae oil provide a balance of omega-3 fatty acids similar to fish oil, with a lower risk of pollutant exposure.
- Moghadasian, Mohammed H. (2008). "Advances in Dietary Enrichment with N-3 Fatty Acids". Critical Reviews in Food Science and Nutrition 48 (5): 402–10. doi:10.1080/10408390701424303. PMID 18464030.
- Cleland, Leslieg; James, Michaelj; Proudman, Susannam (2006). "Fish oil: What the prescriber needs to know". Arthritis Research & Therapy 8 (1): 679–81. doi:10.1186/ar1876. PMC 1526555. PMID 16542466.
- Venturi S, Donati FM, Venturi A, Venturi M (2000). "Environmental iodine deficiency: A challenge to the evolution of terrestrial life?". Thyroid 10 (8): 727–9. doi:10.1089/10507250050137851. PMID 11014322.
- Venturi S, Venturi M (2007). "Evolution of Dietary Antioxidant Defences". European Epi-Marker 11 (3): 1–12.
- Küpper, Frithjof C.; Carpenter, Lucy J.; McFiggans, Gordon B.; Palmer, Carl J.; Waite, Tim J.; Boneberg, Eva-Maria; Woitsch, Sonja; Weiller, Markus; Abela, Rafael; Grolimund, Daniel; Potin, Philippe; Butler, Alison; Luther, George W.; Kroneck, Peter M. H.; Meyer-Klaucke, Wolfram; Feiters, Martin C. (2008). "Iodide accumulation provides kelp with an inorganic antioxidant impacting atmospheric chemistry". Proceedings of the National Academy of Sciences 105 (19): 6954–8. Bibcode:2008PNAS..105.6954K. doi:10.1073/pnas.0709959105. JSTOR 25461906. PMC 2383960. PMID 18458346.
- EPA (2007-01-31). "Fish Consumption Advisories". Retrieved 8 February 2007.
- FAO: World Review of Fisheries and Aquaculture 2008: Highlights of Special Studies Rome.
- Innis, Sheila M.; Rioux, France M.; Auestad, Nancy; Ackman, Robert G. (1995). "Marine and freshwater fish oil varying in arachidonic, eicosapentaenoic and docosahexaenoic acids differ in their effects on organ lipids and fatty acids in growing rats". The Journal of Nutrition 125 (9): 2286–93. PMID 7666244.
- Gruger, E. H.; Nelson, R. W.; Stansby, M. E. (1 October 1964). "Fatty acid composition of oils from 21 species of marine fish, freshwater fish and shellfish". Journal of the American Oil Chemists Society 41 (10): 662–7. doi:10.1007/BF02661403.
- Philibert, A; Vanier, C; Abdelouahab, N; Chan, HM; Mergler, D (December 2006). "Fish intake and serum fatty acid profiles from freshwater fish". The American journal of clinical nutrition 84 (6): 1299–307. PMID 17158409.
- NIH Medline Plus. "MedlinePlus Herbs and Supplements: Omega-3 fatty acids, fish oil, alpha-linolenic acid". Retrieved 14 February 2006.
- Su, Kuan-Pin; Huang, Shih-Yi; Chiu, Chih-Chiang; Shen, Winston W. (2003). "Omega-3 fatty acids in major depressive disorder". European Neuropsychopharmacology 13 (4): 267–71. doi:10.1016/S0924-977X(03)00032-4. PMID 12888186.
- Naliwaiko, K.; Araújo, R.L.F.; Da Fonseca, R.V.; Castilho, J.C.; Andreatini, R.; Bellissimo, M.I.; Oliveira, B.H.; Martins, E.F.; Curi, R.; Fernandes, L.C.; Ferraz, A.C. (2004). "Effects of Fish Oil on the Central Nervous System: A New Potential Antidepressant?". Nutritional Neuroscience 7 (2): 91–9. doi:10.1080/10284150410001704525. PMID 15279495.
- Green, Pnina; Hermesh, Haggai; Monselise, Assaf; Marom, Sofi; Presburger, Gadi; Weizman, Abraham (2006). "Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder". European Neuropsychopharmacology 16 (2): 107–13. doi:10.1016/j.euroneuro.2005.07.005. PMID 16243493.
- Yehuda, Shlomo; Rabinovitz, Sharon; Mostofsky, David I. (2005). "Mixture of essential fatty acids lowers test anxiety". Nutritional Neuroscience 8 (4): 265–7. doi:10.1080/10284150500445795. PMID 16491653.
- Nemets, B.; Stahl, Z; Belmaker, RH (2002). "Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive Disorder". American Journal of Psychiatry 159 (3): 477–9. doi:10.1176/appi.ajp.159.3.477. PMID 11870016.
- Falk-Petersen, S.; Sargent, J. R.; Henderson, J.; Hegseth, E. N.; Hop, H.; Okolodkov, Y. B. (1998). "Lipids and fatty acids in ice algae and phytoplankton from the Marginal Ice Zone in the Barents Sea". Polar Biology 20 (1): 41–7. doi:10.1007/s003000050274. INIST:2356641.
- "Fish, Levels of Mercury and Omega-3 Fatty Acids". American Heart Association. Retrieved 6 October 2010.
- Kris-Etherton, Penny M.; William S. Harris, Lawrence J. Appel (2002). "Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease". Circulation 106 (21): 2747–57. doi:10.1161/01.CIR.0000038493.65177.94. PMID 12438303.
- "Omega-3 Centre". Omega-3 sources. Omega-3 Centre. Archived from the original on 2008-07-18. Retrieved 27 July 2008.
- Augustsson, Katarina; Michaud, Dominique S.; Rimm, Eric B.; Leitzmann, Michael F.; Stampfer, Meir J.; Willett, Walter C.; Giovannucci, Edward (2003). "A Prospective Study of Intake of Fish and Marine Fatty Acids and Prostate Cancer". Cancer epidemiology, biomarkers & prevention 12 (1): 64–7. PMID 12540506.
- De Deckere, E A M (1999). "Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer". European Journal of Cancer Prevention 8 (3): 213–21. doi:10.1097/00008469-199906000-00009. PMID 10443950.
- Caygill, C P J; Hill, M J (1995). "Fish, n-3 fatty acids and human colorectal and breast cancer mortality". European Journal of Cancer Prevention 4 (4): 329–32. doi:10.1097/00008469-199508000-00008. PMID 7549825.
- Pala, V.; Krogh, V; Muti, P; Chajès, V; Riboli, E; Micheli, A; Saadatian, M; Sieri, S; Berrino, F (2001). "Erythrocyte Membrane Fatty Acids and Subsequent Breast Cancer: a Prospective Italian Study". Journal of the National Cancer Institute 93 (14): 1088–95. doi:10.1093/jnci/93.14.1088. PMID 11459870.
- Laurance, Jeremy (2010-07-08). "Fish supplements may reduce risk of cancer". The Independent (London).
- Berquin, Isabelle M.; Min, Younong; Wu, Ruping; Wu, Jiansheng; Perry, Donna; Cline, J. Mark; Thomas, Mike J.; Thornburg, Todd; Kulik, George; Smith, Adrienne; Edwards, Iris J.; d'Agostino, Ralph; Zhang, Hao; Wu, Hong; Kang, Jing X.; Chen, Yong Q. (2007). "Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids". Journal of Clinical Investigation 117 (7): 1866–75. doi:10.1172/JCI31494. PMC 1890998. PMID 17607361.
- Heinze, VM; Actis, AB (February 2012). "Dietary conjugated linoleic acid and long-chain n-3 fatty acids in mammary and prostate cancer protection: a review". International journal of food sciences and nutrition 63 (1): 66–78. doi:10.3109/09637486.2011.598849. PMID 21762028.
- Chua, Michael E.; Sio, Maria Christina D.; Sorongon, Mishell C.; Morales Jr, Marcelino L. Jr. (May–June 2013). "The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: a meta-analysis". Canadian Urological Association Journal 7 (5–6): E333–43. doi:10.5489/cuaj.1056. PMC 3668400. PMID 23766835.
- "Fish and Omega-3 Fatty Acids". American Heart Association. Retrieved 9 February 2007.
- Charnock John S (1999). "The role of omega-3 polyunsaturated fatty acid-enriched diets in the prevention of ventricular fibrillation". Asia Pacific Journal of Clinical Nutrition 8 (3): 226–30. doi:10.1046/j.1440-6047.1999.00115.x. PMID 24394167.
- Li G-R Sun H-Y, Zhang X-H Cheng L-C, Chiu S-W Tse H-F, Lau C-P (2009). "Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes". Cardiovasc Res 81 (2): 286–93. doi:10.1093/cvr/cvn322. PMID 19029136.
- Nair, G. M.; Connolly, S. J. (2008). "Should patients with cardiovascular disease take fish oil?". Canadian Medical Association Journal 178 (2): 181–2. doi:10.1503/cmaj.071654. PMC 2174997. PMID 18195293.
- Rizos, E. C.; Ntzani, E. E.; Bika, E; Kostapanos, MS; Elisaf, MS (2012). "Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events: A Systematic Review and Meta-analysis". Journal of the American Medical Association 308 (10): 1024–33. doi:10.1001/2012.jama.11374. PMID 22968891.
- "Omega-3 fatty acids, fish oil, alpha-linolenic acid". Retrieved 4 February 2014.
- Huan, M; Hamazaki, K; Sun, Y; Itomura, M; Liu, H; Kang, W; Watanabe, S; Terasawa, K; Hamazaki, T (2004). "Suicide attempt and n-3 fatty acid levels in red blood cells: A case control study in china". Biological Psychiatry 56 (7): 490–6. doi:10.1016/j.biopsych.2004.06.028. PMID 15450784.
- Mischoulon, David; Papakostas, George I.; Dording, Christina M.; Farabaugh, Amy H.; Sonawalla, Shamsah B.; Agoston, A. Monica; Smith, Juliana; Beaumont, Erin C.; Dahan, Liat E.; Alpert, Jonathan E.; Nierenberg, Andrew A.; Fava, Maurizio (2009). "A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder". The Journal of Clinical Psychiatry 70 (12): 1636–44. doi:10.4088/JCP.08m04603. PMC 2918427. PMID 19709502.
- Mihm, Stephen (16 April 2006). "Does Eating Salmon Lower the Murder Rate?". New York Times Magazine. Retrieved 8 February 2007.
- Gesch, CB; Hammond, SM; Hampson, SE; Eves, A; Crowder, MJ (2002). "Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners". British Journal of Psychiatry 181 (1): 22–8. doi:10.1192/bjp.181.1.22. PMID 12091259.
- Itomura, M.; Hamazaki, K. et al. (2005). "The effect of fish oil on physical aggression in schoolchildren". Journal of Nutritional Biochemistry 16 (3): 163–71. doi:10.1016/j.jnutbio.2004.10.009.
- Benton, D. (2007). "The impact of diet on anti-social, violent and criminal behaviour". Neuroscience & Biobehavioral Reviews 31 (5): 752–74. doi:10.1016/j.neubiorev.2007.02.002.
- Amminger, G. P.; Schäfer, M. R.; Papageorgiou, K.; Klier, C. M.; Cotton, S. M.; Harrigan, S. M.; MacKinnon, A.; McGorry, P. D.; Berger, G. E. (2010). "Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders: A Randomized, Placebo-Controlled Trial". Archives of General Psychiatry 67 (2): 146–54. doi:10.1001/archgenpsychiatry.2009.192. PMID 20124114.
- Knapp, M. (1997). "Costs of schizophrenia". The British Journal of Psychiatry 171 (6): 509–18. doi:10.1192/bjp.171.6.509. PMID 9519088. Lay summary – The Independent (May 26, 1998).
- Dangour, AD; Allen, E; Elbourne, D; Fasey, N; Fletcher, AE; Hardy, P; Holder, GE; Knight, R; Letley, L et al. et al. (2010). "Effect of 2-y n−3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people". American Journal of Clinical Nutrition 91 (6): 1725–32. doi:10.3945/ajcn.2009.29121. PMID 20410089.
- Fish oil 'no benefit' to elderly NHS, 29 April 2010.
- Stoll, Andrew L.; Severus, W. Emanuel; Freeman, Marlene P.; Rueter, Stephanie; Zboyan, Holly A.; Diamond, Eli; Cress, Kimberly K.; Marangell, Lauren B. (1999). "Omega 3 Fatty Acids in Bipolar Disorder". Archives of General Psychiatry 56 (5): 407–12. doi:10.1001/archpsyc.56.5.407. PMID 10232294.
- Stoll, Andrew L. (2002). The Omega-3 Connection: The Groundbreaking Omega-3 Antidepression Diet and Brain Program. Free Press. ISBN 0-684-87139-4.[page needed]
- Baumel, Syd (Fall 2001). "Your Brain on Fats". The Aquarian (The Aquarian Newspaper).
- Rudin, DO (1981). "The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: Substrate pellagra". Biological Psychiatry 16 (9): 837–50. PMID 7028146.
- Silvers, K; Woolley, C; Hamilton, F; Watts, P; Watson, R (2005). "Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression". Prostaglandins, Leukotrienes and Essential Fatty Acids 72 (3): 211–8. doi:10.1016/j.plefa.2004.11.004.
- Grenyer, B; Crowe, T; Meyer, B; Owen, A; Grigonis-Deane, E; Caputi, P; Howe, P (2007). "Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial". Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (7): 1393–6. doi:10.1016/j.pnpbp.2007.06.004. PMID 17659823.
- Montgomery P, Richardson AJ (2008). "Omega-3 fatty acids for bipolar disorder". In Montgomery, Paul. Cochrane Database of Systematic Reviews (2): CD005169. doi:10.1002/14651858.CD005169.pub2. PMID 18425912.
- Martins, Julian G (2009). "EPA but Not DHA Appears to Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials". Journal of the American College of Nutrition 28 (5): 525–42. doi:10.1080/07315724.2009.10719785. PMID 20439549.
- Bloch, M H; Hannestad, J (2011). "Omega-3 fatty acids for the treatment of depression: Systematic review and meta-analysis". Molecular Psychiatry 17 (12): 1272–82. doi:10.1038/mp.2011.100. PMC 3625950. PMID 21931319.
- Sifferlin, Alexandra (June 13, 2012). "Fish Oil Fail: Omega-3s May Not Protect Brain Health After All". Time. Retrieved 19 June 2012.
- Duffy, EM; Meenagh, GK; McMillan, SA; Strain, JJ; Hannigan, BM; Bell, AL (2004). "The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus". The Journal of Rheumatology 31 (8): 1551–6. PMID 15290734.
- Wright, S A; O'Prey, F M; McHenry, M T; Leahey, W J; Devine, A B; Duffy, E M; Johnston, D G; Finch, M B; Bell, A L; McVeigh, G E (2008). "A randomised interventional trial of ω-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus". Annals of the Rheumatic Diseases 67 (6): 841–8. doi:10.1136/ard.2007.077156. PMID 17875549.
- Wolters, M. (2005). "Diet and psoriasis: experimental data and clinical evidence". British Journal of Dermatology 153 (4): 706–14. doi:10.1111/j.1365-2133.2005.06781.x. PMID 16181450.
- Jensen, Craig L.; Voigt, Robert G.; Llorente, Antolin M.; Peters, Sarika U.; Prager, Thomas C.; Zou, Yali L.; Rozelle, Judith C.; Turcich, Marie R.; Fraley, J. Kennard; Anderson, Robert E.; Heird, William C. (2010). "Effects of Early Maternal Docosahexaenoic Acid Intake on Neuropsychological Status and Visual Acuity at Five Years of Age of Breast-Fed Term Infants". The Journal of Pediatrics 157 (6): 900–5. doi:10.1016/j.jpeds.2010.06.006. PMID 20655543.
- Calder, Philip C.; Kremmyda, Lefkothea-Stella; Vlachava, Maria; Noakes, Paul S.; Miles, Elizabeth A. (2010). "Is there a role for fatty acids in early life programming of the immune system?". Proceedings of the Nutrition Society 69 (3): 373–80. doi:10.1017/S0029665110001552. PMID 20462467.
- "ConsumerLab.com Finds Quality Problems with Nearly Thirty Percent of Fish Oil Supplements Reviewed; "Fishy" Claims Identified: Softgels and Liquids for Adults, Children and Pets Tested, Including Krill Oil and Algal Oil Supplements". ConsumerLab.com. 28 September 2010. Retrieved 20 October 2012.[dubious ]
- Reviews of Supplements and Health Products ConsumerLab.
- Aursand, Marit; Mozuraityte, Revilija; Hamre, Kristin; Knutsen, Helle; Maage, Amund; Arukwe, Augustine (2011). Description of the processes in the value chain and risk assessment of decomposition substances and oxidation products in fish oils. Norwegian Scientific Committee for Food Safety. ISBN 978-82-8259-035-8. Retrieved 19 October 2012.[page needed]
- Mercury Levels in Commercial Fish and Shellfish (1990–2010) U.S. Food and Drug Administration. Accessed 25 March 2013.
- "ConsumerLab.com Review: Fish Oil and Omega-3 Fatty Acid Supplements Review (Including Krill, Algae, and Calamari Oil)". ConsumerLab.com. 13 August 2012. Retrieved 19 October 2012.(registration required)
- "ConsumerLab.com Review: Fish Oil and Omega-3 Fatty Acid Supplements Review (Including Krill, Algae, and Calamari Oil): Contaminants in Fish Vs. Supplements: Contaminants in Fish vs. Supplements". ConsumerLab.com. 13 August 2012. Retrieved 19 October 2012.(registration required)
- Villani, Anthony M; Crotty, Maria; Cleland, Leslie G; James, Michael J; Fraser, Robert J; Cobiac, Lynne; Miller, Michelle D (2013). "Fish oil administration in older adults: Is there potential for adverse events? A systematic review of the literature". BMC Geriatrics 13 (1): 41. doi:10.1186/1471-2318-13-41. PMC 3664575. PMID 23634646.
- Can you overdose on DHA and EPA? DHA/EPA Omega-3 Institute. Retrieved 4 November 2011.
- Kantha, SS (1987). "Dietary effects of fish oils on human health: A review of recent studies". The Yale Journal of Biology and Medicine 60 (1): 37–44. PMC 2590235. PMID 3551346.
- Lips, Paul (2003). "Hypervitaminosis a and Fractures". New England Journal of Medicine 348 (4): 347–9. doi:10.1056/NEJMe020167. PMID 12540650.
- Jess Halliday (2006-04-13). "Dioxins prompt second UK fish oil withdrawal". Retrieved 8 February 2007.
- "Pollutants found in fish oil capsules". BBC News. 2002-04-06. Retrieved 8 February 2007.
- International Fish Oil Standards.
- Elisabeth Leamy (2010-03-03). "Lawsuit Raises Fish Oil Supplement Concerns". Retrieved 5 March 2010.
- "Lawsuit says fish oil supplements contain PCB", San Francisco Chronicle, March 3, 2010.
- Brustad, Magritt; Sandanger, Torkjel Manning; Andersen, Vegard; Lund, Eiliv (2007). "POP exposure from fish liver consumption and risk of cancer?the Norwegian Women and Cancer Study". Journal of Environmental Monitoring 9 (7): 682–6. doi:10.1039/B706302B. PMID 17607388.
- Foran, Stacy E.; Flood, James G.; Lewandrowski, Kent B. (2003). "Measurement of Mercury Levels in Concentrated Over-the-Counter Fish Oil Preparations: Is Fish Oil Healthier Than Fish?". Archives of Pathology & Laboratory Medicine 127 (12): 1603–5. doi:10.1043/1543-2165(2003)1271603:MOMLIC2.0.CO;2. PMID 14632570.
- Doughman, Scott D.; Krupanidhi, Srirama; Sanjeevi, Carani B. (2007). "Omega-3 Fatty Acids for Nutrition and Medicine: Considering Microalgae Oil as a Vegetarian Source of EPA and DHA". Current Diabetes Reviews 3 (3): 198–203. doi:10.2174/157339907781368968. PMID 18220672.
|Wikimedia Commons has media related to Fish oil.|
- International Fish Oil Standards — An organization concerned with the quality of omega-3 products as it relates to the international standards established by the World Health Organization and the Council For Responsible Nutrition for purity and concentration.
- Joyce A. Nettleton, ed. "PUFA Newsletter". Retrieved 20 February 2006. Two newsletters, both quarterly, reviewing recent publications in essential fatty acids. One is written for researchers, the second is for consumers. Industry sponsored, academic contributors.
- Omega-3 Fatty Acids American Cancer Society. Updated 11 January 2008.